<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="?"><plain>Does <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> in patients with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumour cerebri</z:e> (PTC) result in <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The results of previous investigations have not clarified this question </plain></SENT>
<SENT sid="2" pm="."><plain>It may be that there is a subgroup within those diagnosed with PTC that does experience <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> with <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>However, <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e>, <z:hpo ids='HP_0002315'>headache</z:hpo>, and <z:e sem="disease" ids="C0700361" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional distress</z:e> also can contribute to reduced cognitive performance and increased self-monitoring </plain></SENT>
<SENT sid="4" pm="."><plain>As a result of the lack of clarity regarding the impact of PTC on cognition clinicians are left with no empirically derived practice guidelines </plain></SENT>
<SENT sid="5" pm="."><plain>A case study demonstrates subjective complaints of concentration and <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in a depressed patient with PTC whose neuropsychological stores (except Seashore Rhythm Test) were in the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
</text></document>